| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3212a21408687fa317886a11960cd9cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1cfcb1fcf40ae9df3e0a0aafb295430
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2011-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9e163e000a31ba178ea415dac5c58a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9957a45da38128e6e09cc9df80b34230 |
| publicationDate |
2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012028334-A2 |
| titleOfInvention |
Marker for sunitinib resistance formation |
| abstract |
The present invention relates to marker for sunitinib resistance formation and modulators thereof for the prevention and reduction of sunitinib resistance of hyperproliferative cells, in particular cancer cells. Further, the present invention relates to compositions comprising agents suitable for anticancer therapy in combination with the modulators for treating proliferative diseases. |
| priorityDate |
2010-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |